Checkpoint Therapeutics, Inc. - Common Stock (CKPT)

Checkpoint Therapeutics Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative treatments for cancer

The company specializes in targeted and immune-oncology therapies, aiming to advance new options for patients suffering from various types of solid tumors. Through its research initiatives and clinical trials, Checkpoint Therapeutics seeks to develop therapies that can effectively address unmet medical needs in oncology, leveraging modern scientific advancements to enhance patient outcomes.